Competition Outlook
Arctiko, VWR International, Global Cooling Inc, BINDER GmbH, Labcold, Helmer scientific, Stirling Ultracold, Eppendorf AG., Esco Micro Pte Ltd., PHC Corporation, Thermo Fisher Scientific Inc., and others are prime players of the ultra-low temperature freezer market.
Market Outlook
The global ultra-low temperature freezer market size is projected to reach USD 897.28 million by 2024. It can exhibit 3.20% CAGR from 2019 to 2024 (forecast period). Increased demand in blood banking storage and leaps in research and development are primary factors driving market growth. Expansion plans of pharmaceutical and biopharmaceutical companies in expanding its research can induce the demand for ULT freezers and refrigerators for storage of biological samples.
The scope in drug discovery and a slew of clinical trials for furthering research in disease prevention can work in favor of the global ultra-low temperature freezer market. Surgeries requiring rare blood and tissues for implants can spur the market demand. According to the report by National Center for Biotechnology of 2016, close to 40,829 hematopoietic stem cells transplant operations were performed across several European countries indicating the positive growth trajectory of the market during the forecast period.
Request a Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1813
Segmentation Analysis
The global ultra-low temperature freezers market is segmented as type, end user, and region.
Based on type, the global market is divided into upright ULT freezers and chest ULT freezers. The former can register a CAGR of 3.30% during the forecast period
On the basis of end user, the global ultra-low temperature freezer market is segmented into bio-banks, hospitals and clinics, and academic & research institutes. The biobanks segment accounted for a market value of USD 341.89 million in 2018. It can register a CAGR of 3.40% during the assessment period due to donations by volunteers and accumulation of biological samples due to prevalence of chronic diseases. Hospitals & clinics were the second largest segment and touted to exhibit a CAGR of 3.29% during the forecast period.
Ultra-low temperature (ULT) freezers are medical devices used for the storage of biological samples of blood, sperm, cells, etc. These freezers are extensively used in blood banks, biomedical engineering facilities, hospitals, research institutes, and epidemic prevention services. They have operating temperatures between the range of -45 and -86 degree Celsius. The global ultra-low temperature freezer market report by Market Research Future (MRFR) contains its importance in biobanking and its future prospects for thep period between 2019 to 2024.
Regional Analysis
The global ultra-low temperature freezers market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas are expected to dominate the global market till 2024 due to large number of healthcare providers and demand for large storage solutions. Strides in biobanking and efforts by hospitals to lower energy consumption can bode well for the regional demand. The growth is facilitated by players such as Panasonic Healthcare which have launched freezers with high operational functions and low power consumption. The region can accrue revenues at 3.30% CAGR during the forecast period.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/ultra-low-temperature-freezer-market-1813
Europe follows the Americas in ranking driven by measures taken by pharmaceutical companies for preservation of biological samples. Inclination towards bio banking and cord blood banking are expected to drive the regional demand exponentially. Europe had a valuation of USD 208.06 million in 2017. It can exhibit a CAGR of 3.14% during the forecast period.
APAC, on the other hand, is expected to experience a robust growth rate due to investments in healthcare infrastructure and subsidies provided to pharmaceutical and biopharmaceutical companies for drug development. Lastly, the MEA has limited growth owing to low awareness levels.
Browse More Healthcare Related Research Reports:
Americas Respiratory Therapeutic Devices Market– Forecast to 2020 | MRFR
Transradial Access Devices Market Research Report –Global Forecast to 2023| MRFR
Drug Infusion System Market Research Report –Global Forecast to 2023| MRFR
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
3D cell cultures are cell cultures where the organism can grow in all three directions, replicating the natural growth patterns of the organism.
In contrast, 2D cell culture media such as petri dishes do not allow for 360-degree growth of the organism’s cell clusters, leading to a more limited understanding of the organism, its propagation, and its mechanism.
3D cell cultures allow for a more comprehensive study of the respective organism by replicating in vivo conditions and are thus growing in demand in the medical research sector due to their benefits in terms of acquiring more detailed profiles of the subjects in question.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/5928Regional Analysis: 3D Cell Culture MarketThe Americas, led by the U.S., is the largest contributor to the global 3D cell culture market and is likely to retain the position over the forecast period due to the strong presence of a number of leading pharmaceutical and biotech companies in the region and the growing emphasis in the region on drug development and medical research.Asia Pacific is expected to exhibit the highest growth in the global 3D cell culture market over the forecast period due to the growing presence of biotech and pharmaceutical companies in the region.Segmentation: 3D Cell Culture MarketThe global 3D cell culture market is segmented on the basis of technique, product, application, end user, and region.On the basis of technique, the global 3D cell culture market is segmented into scaffold-based 3D Cell cultures and scaffold-free 3D cell cultures.On the basis of the product, the market is segmented into consumables and instruments.
The consumables segment dominates the global 3D cell culture market and is expected to grow at a CAGR of 25.88% over the forecast period from 2017 to 2023.On the basis of application, the 3D cell culture market is segmented into cancer research, stem cell research, drug discovery, tissue screening and engineering, regenerative medicine, and others.
Drug discovery is the largest application segment of the global 3D cell culture market and is likely to exhibit stable progress over the forecast period at a CAGR of 25.75%.On the basis of end use, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, research and academic laboratories, and others.
Pharmaceutical and biotechnology companies are likely to remain the leading end user in the global 3D cell culture market over the forecast period, exhibiting growth at a strong 26.13% CAGR over the forecast period.For More Details: https://www.marketresearchfuture.com/reports/3d-cell-culture-market-5928NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries.
OTR(Off the road) Tires Tire Market:WiseGuyReports.com adds “Global OTR(Off the road) Tires Tire Market Research Report 2020 Analysis and Forecast 2026” reports to its database.Executive SummaryGlobal OTR Tire Market is valued approximately at USD 5.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 4.80% over the forecast period 2019-2026.
The OTR tire market is primarily driven owing to surging sales of off-highway vehicles, surging construction sector in both developed and developing countries, escalating utility of commercial vehicles along with government subsidies on agricultural equipment’s.
However, the impact of Covid-19 has negatively impacted the transportation & logistics sector in both developed and developing countries which is anticipated to be a restraining factor for the surge and demand of OTR tires.
Around 23846003 units of commercial vehicles were produced in the year 2017 as compared to 72105435 units in the year 2016 on the global scenario.
However, the high cost of OTR Tires impedes the growth of the market over the forecast period of 2020-2026.Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5278116-global-otr-off-the-road-tires-tire-marketThe regional analysis of global OTR Tire market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
North America is the leading/significant region across the world in terms of market share owing to the surging construction sector which include both residential and commercial vehicles along with subsidies provided by federal government for agricultural equipment.
Global Blue Biotechnology market, by Product (Enzymes, Pharma Products, Bulk Chemicals, Biopolymers), by Application (Bio-Engineering, Genomics, Vaccine Development, Drug Discovery, Others), by End-Users (Hospitals, Labs) – Forecast Till 2027Blue Biotechnology Market – OverviewThe use of aquatic and marine organisms to extract new active ingredients among other applications is motivating the blue biotechnology market.
The augmented application of blue biotechnology in life science and healthcare sectors is expected to create the further impetus for market expansion.
As per the report, the North American region is expected to be accredited for the principal market share and will continue to control its top position over the forecast period owing to the growing awareness and the increasing demand about the blue biotechnology products in vaccine development.
The presence of a vast number of biotechnology companies concerned in research and development activities in blue biotechnology, rising demand of aquatic biotechnology in the cosmetics manufacturing industry and amplifying number of end-users’ applications like pharmaceutical, cosmetic, and others drive the development of this market.
The increasing focus on marine technology for the development of innovative drug has augmented the development of blue biotechnology market in the European region.
The Middle Eastern and African regional market is anticipated to be responsible for the minimum share of the blue biotechnology market owing to a small healthcare sector, absence of technical knowledge, and meager medical facilities.Competitive AnalysisThe fiscal policies that are in effect in the market are expected to lead to a robust pace of development.
Blue Biotechnology Market – OverviewThe use of aquatic and marine organisms to extract new active ingredients among other applications is motivating the blue biotechnology market.
The augmented application of blue biotechnology in life science and healthcare sectors is expected to create the further impetus for market expansion.
Based on the region, the blue biotechnology market is segmented into Europe, the Americas, Asia Pacific, Africa, and the Middle East.Detailed Regional Analysis The assessment of the regions in the blue biotechnology market covers regions like Europe, the Americas, Asia Pacific, Africa, and the Middle East.
The presence of a vast number of biotechnology companies concerned in research and development activities in blue biotechnology, rising demand of aquatic biotechnology in the cosmetics manufacturing industry and amplifying number of end-users’ applications like pharmaceutical, cosmetic, and others drive the development of this market.
The increasing focus on marine technology for the development of innovative drug has augmented the development of blue biotechnology market in the European region.
The Middle Eastern and African regional market is anticipated to be responsible for the minimum share of the blue biotechnology market owing to a small healthcare sector, absence of technical knowledge, and meager medical facilities.Competitive AnalysisThe fiscal policies that are in effect in the market are expected to lead to a robust pace of development.
